As of 2026-03-31, 利生奇珠单抗's data on the DeepSeek platform in the 医疗保健 category shows: The overall mention rate is 0.00%, below the industry average by 0.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 利生奇珠单抗's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
利生奇珠单抗's Mention Rate is 0.00%, lower than 0.6% of competitors
利生奇珠单抗's First Mention is 0.00%, lower than 0.9% of competitors
利生奇珠单抗's Preferred Rate is 0.00%, lower than 100.0% of competitors
利生奇珠单抗's Positive Rate is 0.00%, lower than 8.9% of competitors
利生奇珠单抗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 国国药控股 | 1.79% | 0% | 0% | 1.79% | 0% | View Details |
| 司司美格鲁肽 | 1.79% | 0% | 0% | 0% | 0% | View Details |
| 修修美乐 | 0% | 0% | 0% | 0% | 0% | View Details |
| 替替尔泊肽 | 0% | 0% | 0% | 0% | 0% | View Details |
| 泽泽布替尼 | 0% | 0% | 0% | 0% | 0% | View Details |
| 可可瑞达 | 0% | 0% | 0% | 0% | 0% | View Details |
| 利利生奇珠单抗 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
